MedPath

University Of Maryland, Baltimore

University Of Maryland, Baltimore logo
🇺🇸United States
Ownership
-
Established
1807-01-01
Employees
7.3K
Market Cap
-
Website
http://www.umaryland.edu

Randomized Controlled Trial of a Gluten Free Diet In Patients With Schizophrenia Who Are Gliadin-Positive

Not Applicable
Completed
Conditions
Schizophrenia
Interventions
Other: Gluten Free Flour
Other: Wheat Flour
First Posted Date
2013-08-22
Last Posted Date
2019-09-27
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
26
Registration Number
NCT01927276
Locations
🇺🇸

Maryland Psychiatric Research Center, Catonsville, Maryland, United States

Robotic Single Port Donor Nephrectomy

Not Applicable
Completed
Conditions
Renal Transplant Donor of Left Kidney
Robotic Surgery
Single-port
Donor Nephrectomy
Interventions
Device: da Vinci® Single-Site™
First Posted Date
2013-08-20
Last Posted Date
2019-11-20
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
3
Registration Number
NCT01925677
Locations
🇺🇸

University of Maryland Medical Center, Baltimore, Maryland, United States

Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344)

Not Applicable
Terminated
Conditions
Brain Tumor
RECURRENT GLIOBLASTOMA
Interventions
Device: Optune(NOVOTTF-100A)
First Posted Date
2013-08-19
Last Posted Date
2022-02-03
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
7
Registration Number
NCT01925573
Locations
🇺🇸

Ummc Msgcc, Baltimore, Maryland, United States

HER2-positive Breast Cancer With Brain Metastasis (GCC 1345)

Phase 2
Withdrawn
Conditions
Breast Cancer With Brain Metastasis
Interventions
Radiation: Stereotactic Radiosurgery plus HER-2 directed therapy in HER2-positive Breast Cancer with Brain Metastasis
First Posted Date
2013-08-16
Last Posted Date
2020-03-18
Lead Sponsor
University of Maryland, Baltimore
Registration Number
NCT01924351
Locations
🇺🇸

Ummc Msgcc, Baltimore, Maryland, United States

Metabolic Actions of Omega-3 Fatty Acids

Not Applicable
Completed
Conditions
Metabolic Syndrome
Interventions
Dietary Supplement: Placebo
Dietary Supplement: EPA (marine fatty acids)
First Posted Date
2013-07-11
Last Posted Date
2020-01-14
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
40
Registration Number
NCT01896414
Locations
🇺🇸

Amish Research Center, Lancaster, Pennsylvania, United States

🇺🇸

University of Maryland Medical Center, Baltimore, Maryland, United States

Switch to Maraviroc + Integrase Inhibitor

Phase 3
Completed
Conditions
HIV
Interventions
Drug: Switch to Maraviroc + Raltegravir or Dolutegravir
First Posted Date
2013-07-11
Last Posted Date
2021-10-20
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
7
Registration Number
NCT01896921
Locations
🇺🇸

University of Maryland, Institute of Human Virology, Baltimore, Maryland, United States

Acupuncture in Reducing the Severity of Chemoradiation-induced Mucositis in Patients With Oropharyngeal Cancer

Not Applicable
Terminated
Conditions
Oropharyngeal Cancer
Mucositis
Interventions
Other: Usual medical care
Device: Acupuncture with Seirin® needles
First Posted Date
2013-06-21
Last Posted Date
2019-11-07
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
4
Registration Number
NCT01883908
Locations
🇺🇸

University of Maryland Marlene & Stewart Greenebaum Cancer Center, Baltimore, Maryland, United States

Acupuncture to Prevent Chemotherapy Dose Reduction Due to Chemotherapy-induced Peripheral Neuropathy in Breast and Colorectal Cancer Patients (GCC1232)

Not Applicable
Terminated
Conditions
Breast Cancer
Colorectal Cancer
Interventions
Device: Sham Acupuncture using Park Sham placebo acupuncture device
Device: Acupuncture using Seirin® needles
First Posted Date
2013-06-20
Last Posted Date
2019-11-07
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
19
Registration Number
NCT01881932
Locations
🇺🇸

University of Maryland Marlene & Stewart Greenebaum Cancer Center, Baltimore, Maryland, United States

PKD Clinical and Translational Core Study

Recruiting
Conditions
Polycystic Kidney Disease
First Posted Date
2013-06-10
Last Posted Date
2024-08-23
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
350
Registration Number
NCT01873235
Locations
🇺🇸

University of Maryland School of Medicine General Clinical Research Center, Baltimore, Maryland, United States

Spray Cryotherapy for Esophageal Cancer (ICE-CANCER)

Not Applicable
Terminated
Conditions
Esophageal Cancer
Interventions
Device: Liquid nitrogen spray cryotherapy with the truFreeze device
First Posted Date
2013-06-04
Last Posted Date
2022-03-07
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
1
Registration Number
NCT01868139
Locations
🇺🇸

University of Maryland Medical Center, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath